Class Action Alert for GoodRx Holdings Inc. (GDRX) Investors

SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) — A legal notice has been issued to inform shareholders about a class action lawsuit representing all individuals and entities that have purchased or otherwise obtained securities of GoodRx Holdings, Inc. GDRX, the healthcare company providing tools for price comparison and savings on prescription drugs, during the period from September 23, 2020, to November 8, 2022. The class action aims to address concerns regarding potential violations of federal securities laws.

About GoodRx Holdings, Inc.

Based in Santa Monica, California, GoodRx Holdings, Inc. GDRX is dedicated to offering consumers vital information and tools to compare prices and achieve cost savings on prescription medications. They have established a trusted platform used by millions in the United States seeking affordable healthcare solutions.

Allegations and Litigation

The lawsuit, filed on behalf of GDRX shareholders, alleges that the company may have provided misleading information or failed to disclose important facts during the specified period, thus affecting the securities' value and investor trust. Shareholders who have been affected are encouraged to participate in the class action and can reach out to the law firm, Robbins LLP, for further details on the case and their legal rights.

lawsuit, shareholders, investing